WallStreetZenWallStreetZen

NASDAQ: BBNX
Beta Bionics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BBNX

Based on 5 analysts offering 12 month price targets for Beta Bionics Inc

Min Forecast
$16.00-39.42%
Avg Forecast
$20.80-21.24%
Max Forecast
$30.00+13.59%

Should I buy or sell BBNX stock?

Based on 5 analysts offering ratings for Beta Bionics Inc.

Buy
Strong Buy
2 analysts 40%
Buy
1 analysts 20%
Hold
2 analysts 40%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BBNX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BBNX as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their BBNX stock forecasts and price targets.

BBNX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-07-30
lockedlocked$00.00+00.00%2025-07-30
lockedlocked$00.00+00.00%2025-06-12
lockedlocked$00.00+00.00%2025-05-30
lockedlocked$00.00+00.00%2025-05-30

1 of 1

Forecast return on equity

Is BBNX forecast to generate an efficient return?

Company
-21.38%
Industry
26.25%
Market
-52.16%
BBNX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BBNX forecast to generate an efficient return on assets?

Company
-19.54%
Industry
13.6%
BBNX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BBNX earnings per share forecast

What is BBNX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$1.75
Avg 2 year Forecast
-$1.93
Avg 3 year Forecast
-$1.87

BBNX revenue forecast

What is BBNX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$92.0M
Avg 2 year Forecast
$126.1M
Avg 3 year Forecast
$166.9M

BBNX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BBNX$26.41$20.80-21.24%Buy
SSII$5.80N/AN/A
IART$15.06$17.25+14.54%Hold
ESTA$37.47$56.25+50.14%Buy
AHCO$9.29$13.00+39.94%Strong Buy
View Top Medical Device Stocks

Beta Bionics Stock Forecast FAQ

Is Beta Bionics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: BBNX) stock is to Buy BBNX stock.

Out of 5 analysts, 2 (40%) are recommending BBNX as a Strong Buy, 1 (20%) are recommending BBNX as a Buy, 2 (40%) are recommending BBNX as a Hold, 0 (0%) are recommending BBNX as a Sell, and 0 (0%) are recommending BBNX as a Strong Sell.

If you're new to stock investing, here's how to buy Beta Bionics stock.

What is BBNX's earnings growth forecast for 2025-2027?

(NASDAQ: BBNX) Beta Bionics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 11.46%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.29%.

Beta Bionics's earnings in 2025 is N/A.On average, 3 Wall Street analysts forecast BBNX's earnings for 2025 to be -$75,929,267, with the lowest BBNX earnings forecast at -$79,550,329, and the highest BBNX earnings forecast at -$69,552,200. On average, 5 Wall Street analysts forecast BBNX's earnings for 2026 to be -$83,810,401, with the lowest BBNX earnings forecast at -$96,068,976, and the highest BBNX earnings forecast at -$57,815,266.

In 2027, BBNX is forecast to generate -$81,397,809 in earnings, with the lowest earnings forecast at -$102,154,794 and the highest earnings forecast at -$43,470,125.

What is BBNX's revenue growth forecast for 2025-2027?

(NASDAQ: BBNX) Beta Bionics's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.51%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.

Beta Bionics's revenue in 2025 is N/A.On average, 3 Wall Street analysts forecast BBNX's revenue for 2025 to be $4,000,251,313, with the lowest BBNX revenue forecast at $3,955,781,375, and the highest BBNX revenue forecast at $4,036,635,808. On average, 3 Wall Street analysts forecast BBNX's revenue for 2026 to be $5,482,017,464, with the lowest BBNX revenue forecast at $5,203,373,963, and the highest BBNX revenue forecast at $5,772,832,600.

In 2027, BBNX is forecast to generate $7,254,859,572 in revenue, with the lowest revenue forecast at $6,776,992,488 and the highest revenue forecast at $7,688,126,308.

What is BBNX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: BBNX) forecast ROA is -19.54%, which is lower than the forecast US Medical Devices industry average of 13.6%.

What is BBNX's Price Target?

According to 5 Wall Street analysts that have issued a 1 year BBNX price target, the average BBNX price target is $20.80, with the highest BBNX stock price forecast at $30.00 and the lowest BBNX stock price forecast at $16.00.

On average, Wall Street analysts predict that Beta Bionics's share price could fall to $20.80 by Jul 30, 2026. The average Beta Bionics stock price prediction forecasts a potential downside of 21.24% from the current BBNX share price of $26.41.

What is BBNX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BBNX) Beta Bionics's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that BBNX's EPS will be -$1.75 for 2025, with the lowest EPS forecast at -$1.83, and the highest EPS forecast at -$1.60. On average, analysts forecast that BBNX's EPS will be -$1.93 for 2026, with the lowest EPS forecast at -$2.21, and the highest EPS forecast at -$1.33. In 2027, BBNX's EPS is forecast to hit -$1.87 (min: -$2.35, max: -$1.00).

What is BBNX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: BBNX) forecast ROE is -21.38%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.